Progression, remission, regression of chronic renal diseases

被引:415
作者
Ruggenenti, P
Schieppati, A
Remuzzi, G [1 ]
机构
[1] Osped Riuniti Bergamo, Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24125 Bergamo, Italy
[2] Osped Riuniti Bergamo, Nephrol Unit, I-24125 Bergamo, Italy
关键词
D O I
10.1016/S0140-6736(00)04728-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of chronic renal disease is increasing worldwide. Most chronic nephropathies lack a specific treatment and progress relentlessly to end-stage renal disease. However, research in animals and people has helped our understanding of the mechanisms of this progression and has indicated possible preventive methods. The notion of renoprotection is developing into a combined approach to renal diseases, the main measures being pharmacological control of blood pressure and reduction of proteinuria. Lowering of blood lipids, smoking cessation, and tight glucose control for diabetes also form part of the multimodal protocol for management of renal patients. With available treatments, dialysis can be postponed for many patients with chronic nephropathies, but the real goal has to be less dialysis-in other words remission of disease and regression of structural damage to the kidney. Experimental and clinical data lend support to the notion that less dialysis (and maybe none for some patients) is at least possible.
引用
收藏
页码:1601 / 1608
页数:8
相关论文
共 75 条
  • [1] Abbate M, 1998, J AM SOC NEPHROL, V9, P1213
  • [2] THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT
    ANDERSON, S
    RENNKE, HG
    BRENNER, BM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) : 1993 - 2000
  • [3] [Anonymous], KIDNEY
  • [4] ADDITIVE EFFECTS OF COMBINED ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ANGIOTENSIN-II ANTAGONISM ON BLOOD-PRESSURE AND RENIN RELEASE IN SODIUM-DEPLETED NORMOTENSIVES
    AZIZI, M
    CHATELLIER, G
    GUYENE, TT
    MURIETAGEOFFROY, D
    MENARD, J
    [J]. CIRCULATION, 1995, 92 (04) : 825 - 834
  • [5] Premature cardiovascular disease in chronic renal failure
    Baigent, C
    Burbury, K
    Wheeler, D
    [J]. LANCET, 2000, 356 (9224) : 147 - 152
  • [6] Effects of an ACE inhibitor calcium antagonist combination on proteinuria in diabetic nephropathy
    Bakris, GL
    Weir, MR
    DeQuattro, V
    McMahon, FG
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (04) : 1283 - 1289
  • [7] Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes
    Benigni, A
    Colosio, W
    Brena, C
    Bruzzi, I
    Bertani, T
    Remuzzi, G
    [J]. DIABETES, 1998, 47 (03) : 450 - 456
  • [8] Endothelin antagonists
    Benigni, A
    Remuzzi, G
    [J]. LANCET, 1999, 353 (9147) : 133 - 138
  • [9] Boner G, 1996, DIABETOLOGIA, V39, P587
  • [10] BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104